A safety and efficacy of sofosbuvir (SOF) and ribavirin (RBV) for genotype 2 hepatitis C virus (HCV)‐infected patients with renal dysfunction.
Latest Information Update: 22 Jul 2018
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2018 New trial record
- 01 Jun 2018 Results published in the Hepatology Research